Market Segmentation
By Drug (Revenue, USD Bn, 2021-2033)
- Lenalidomide
- Decitabine
- Azacitidine
- Luspatercept
- Phase 3 Drugs
By Route of Administration (Revenue, USD Bn, 2021-2033)
- Injection
- Oral
By Distribution Channel (Revenue, USD Bn, 2021-2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region (Revenue, USD Bn, 2021-2033)
- U.S.
- Europe
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- China